ACBI1
ACBI1 is a potent and cooperative SMARCA2, SMARCA4 and PBRM1 degrader with DC50s of 6, 11 and 32 nM, respectively. ACBI1 is a PROTAC degrader. ACBI1 shows anti-proliferative activity. ACBI1 induces apoptosis[1].
Product Specifications
CAS Number
[2375564-55-7]
UNSPSC
12352005
Hazard Statement
H302, H312, H332
Target
Apoptosis; PROTACs; SWI/SNF Complex
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/acbi1.html
Purity
99.92
Solubility
DMSO : ≥ 100 mg/mL
Smiles
CC(N=CS1)=C1C2=CC=C(CNC([C@@H]3C[C@@H](O)CN3C([C@H](C(C)(C)C)NC(C4(CC4)F)=O)=O)=O)C(OCCOC5=CC=C(CN6CCN(C7=CC(C8=C(O)C=CC=C8)=NN=C7N)CC6)C=C5)=C2
Molecular Formula
C49H58FN9O7S
Molecular Weight
936.10
Precautions
H302, H312, H332
References & Citations
[1]Farnaby W, et al. BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design. Nat Chem Biol. 2019 Jul;15 (7) :672-680.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Protein Polybromo-1; SMARCA2; SMARCA4; von Hippel-Lindau (VHL)
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Burkholderia mallei Cytidylate kinase (cmk)
Recombinant Burkholderia mallei Cytidylate kinase (cmk)
Recombinant Burkholderia mallei Cytidylate kinase (cmk)
Recombinant Burkholderia mallei Cytidylate kinase (cmk)
Recombinant Burkholderia mallei Cytidylate kinase (cmk)